Stacey L. Hembruff
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 6
-
- Protein Degradation and Inhibitors 3
- Cancer therapeutics and mechanisms 3
- Retinoids in leukemia and cellular processes 3
- Gene expression and cancer classification 3
- Epigenetics and DNA Methylation 2
- Cell Biology top 10%
- Microtubule and mitosis dynamics 4
-
- Acute Myeloid Leukemia Research 2
- Co-authors
- Amadeo M. ParissentiDavid J. VilleneuveNikki ChengZachary VeitchBaoqing GuoKapil N. BhallaWarren FiskusRekha Rao
- Partner nations
- United StatesCanada
In The Last Decade
Stacey L. Hembruff
22 papers receiving 873 citations
Peers
Comparison fields: 5 of 81
- Oncology 351
- Cancer Research 149
- Molecular Biology 583
- Cell Biology 112
- Genetics 67
Countries citing papers authored by Stacey L. Hembruff
This map shows the geographic impact of Stacey L. Hembruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey L. Hembruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey L. Hembruff more than expected).
Fields of papers citing papers by Stacey L. Hembruff
This network shows the impact of papers produced by Stacey L. Hembruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey L. Hembruff. The network helps show where Stacey L. Hembruff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stacey L. Hembruff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2012 | 40 | |
| 4 | 2012 | 96 | |
| 5 | 2012 | 56 | |
| 6 | 2012 | 27 | |
| 7 | 2011 | 83 | |
| 8 | 2011 | 75 | |
| 9 | 2011 | 3 | |
| 10 | 2010 | 40 | |
| 11 | 2009 | 44 | |
| 12 | Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. | 2009 | 53 |
| 13 | 2008 | 66 | |
| 14 | 2008 | 44 | |
| 15 | 2007 | 5 | |
| 16 | 2007 | 14 | |
| 17 | 2005 | 32 | |
| 18 | 2005 | 45 | |
| 19 | 2004 | 57 | |
| 20 | 2003 | 29 |
About Stacey L. Hembruff
Stacey L. Hembruff is a scholar working on Aging, Oncology and Cell Biology, having authored 23 papers that have together received 890 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Microtubule and mitosis dynamics (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer therapeutics and mechanisms (3 papers), Retinoids in leukemia and cellular processes (3 papers), Gene expression and cancer classification (3 papers), Acute Myeloid Leukemia Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Oncology (351 citations), Cancer Research (149 citations) and Molecular Biology (583 citations). Stacey L. Hembruff has collaborated with scholars based in United States and Canada. Frequent co-authors include Amadeo M. Parissenti, David J. Villeneuve, Nikki Cheng, Zachary Veitch, Baoqing Guo, Kapil N. Bhalla, Warren Fiskus, Rekha Rao, Ramesh Balusu and Li Yang. Their work appears in journals such as Blood, Cancer Research and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.